Clinical Trial Update: New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis [Phase 2]

View source ↗

Summary

This document reports an update on a Phase 2 clinical trial evaluating immunomodulatory therapy strategies for chronic Reactive Arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reactive Arthritis

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Reactive Arthritis | Phase 2 | Status: UNKNOWN